Egypt's Integrated Diagnostics plans London IPO
This article was originally published in Clinica
Executive Summary
Egyptian lab services group Integrated Diagnostics is planning a £200m ($300m) IPO on the London Stock Exchange, giving it a market cap of around £500m.